MGAT5 and autoimmune disease: These results suggest that recipient mice lacking Mgat5-modified glycans are more susceptible to EAE autoimmune disease following adoptive transfer of encephalitogenic Mgat5−/− T cells, implicating cells of the host's own immune or central nervous system.